Methodology Pricing

Inhibikase Therapeutics, Inc.

IKT

HealthcareBiotechnologyNASDAQ

$1.68

Market Cap: $119.28M

Valuation Financials Forecast Compare Historical Price Solvency Dividends Transactions People

Dividends

This section is coming soon.

SweetValueLab

Find the sweet spot to buy. 9 valuation models, updated daily.

Product

Methodology
Pricing
About

Popular Stocks

AAPL Valuation
NVDA Valuation
MSFT Valuation
GOOGL Valuation
AMZN Valuation

Valuation Models

DCF Growth Exit
DCF EBITDA Exit
P/E Multiples
EV/EBITDA Multiples
PEG Ratio

© 2026 Sweet Value Lab. All rights reserved.

Not financial advice. Data may be delayed.